Sign in
SuspendedNo phase

A Novel Computer-Based Therapy for Social Anxiety

Key facts

Who runs it
New York State Psychiatric Institute
Where
New York, United StatesSee the site
Trial code
Status
Suspended
People taking part
60 people, planned
Started
25 Aug 2017
Expected to end
1 Dec 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • GC-MRT
  • modified GC-MRT
  • Non-GC-MRT
Record updated
4 February 2026
Why it stopped
funding unavailable

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Males and females between the ages of 18 and 60
  • Current DSM-V primary diagnosis of SAD
  • Score of at least 50 on the Liebowitz Social Anxiety Scale (Self-rated version)
  • Fluent in English and willing and able to give informed written consent and participate responsibly in the protocol
  • Normal or corrected-to-normal vision

Who cannot take part

  • Any concurrent cognitive behavioral therapy; other psychotherapy that was initiated in the past 3 months
  • Paramagnetic metallic implants or devices contraindicating magnetic resonance imaging or any other non-removable paramagnetic metal in the body (e.g. pacemaker, paramagnetic metallic prosthesis, surgical clips, shrapnel, necessity for constant medicinal patch, some tattoos)
  • Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder, or bipolar disorder
  • Current diagnosis of PTSD, obsessive-compulsive disorder, bipolar disorder, manic episode or tic disorder
  • Current or past organic mental disorder, seizure disorder, epilepsy or brain injury
  • Current unstable or untreated medical illness
  • Severe alcohol use disorder, severe cannabis use disorder, and any severity of other substance use disorder (except nicotine use disorders allowed)
  • Use of psychiatric medication in the past month other than a stable dose of selective serotonin reuptake inhibitors (SSRIs) for a least 3 months
  • Current severe depression
  • Suicidal ideation or behavior
  • Pregnancy, or plans to become pregnant during the period of the study - will be assessed by Urine β-HCG
  • Contraindication to MRI scanning:
  • Being unable to tolerate the scanning procedures (i.e., severe obesity, claustrophobia)

Where in United States

  • New York State Psychiatric InstituteNew York, United States

About the trial

What the trial wants to find out

The present study is a double blind trial that seeks to examine the feasibility, acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy (GC-MRT) in individuals with social anxiety disorder (SAD)

The 3 groups in the trial

  • GC-MRTTreatment being tested

    Group 1 will receive a 4-week (8-sessions) course of standard GC-MRT

  • non-GC-MRTExisting treatment, for comparison

    Group 2 will receive a 4-week (8-sessions) course of non-GC-MRT

  • GC-MRT-modifiedTreatment being tested

    Group 3 will receive a 4-week (8-sessions) course of modified GC-MRT.

    Treatment: modified GC-MRT

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
4 February 2026